SPOTLIGHT -
ASCRS 2023: Comparing outcomes of 2 different trabecular MIGS devices with or without ab interno canaloplasty for patients with glaucoma
Ophthalmology Times® spoke with Mitch Shultz, MD at ASCRS 2023 in San Diego where he shared insights from his presentation comparing patient results of the Hydrus stent and the iStent inject W with or without ABiC (or ab-interno canaloplasty).